Alzheimer's & Cognition
News from the FDA/CDC
The FDA targeted more than 58 products.
From the Journals
The approach will need to be validated and translated “to a simpler automated platform suitable for wider utility.”
Evidence suggests combining lifestyle modifications may yield better cognitive outcomes.
What Your Patients are Hearing
Interviews with couple chronicle the devastating impact the disease can have on families.
The molecule will continue to be tested in a study of familial Alzheimer’s in Colombia.
Clinicians are calling blood pressure drugs the first disease-modifying therapy for MCI.
People with higher degrees of frailty may be more likely to have more Alzheimer’s disease pathology and clinical dementia.
A cholinesterase inhibitor plus memantine may be more effective than either medication alone.
EEG studies and brain imaging concur: Disrupted sleep patterns are associated with tau and amyloid in Alzheimer’s-affected regions and...
Cases That Test Your Skills
Ms. D, age 62, is disoriented, distractible, tearful, and tangential. She reports that 'aerialists' are climbing through her windows at night and...
The finding hints that improving obstructive sleep apnea in mid-life could reduce the later risk of Alzheimer’s disease.